☰

Gabor Barna, Ph.D. - Publications

Affiliations: 
2005 Semmelweis Egyetem, Hungary 
Area:
Pathology, Oncology, Cell Biology
Tree Info Similar researchers PubMed Report error

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Dankó T, Petővári G, Sztankovics D, Moldvai D, Raffay R, Lőrincz P, Visnovitz T, Zsiros V, Barna G, Márk Á, Krencz I, Sebestyén A. Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells. International Journal of Molecular Sciences. 22. PMID 34360785 DOI: 10.3390/ijms22158019  0.34
2021 Kriston C, Hernádfői M, Plander M, Márk Á, Takács F, Czeti Á, Szalóki G, Szabó O, Matolcsy A, Barna G. Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia. Hematological Oncology. PMID 34013974 DOI: 10.1002/hon.2888  0.402
2020 Kárai B, Gyurina K, Ujfalusi A, Sędek Ł, Barna G, Jáksó P, Svec P, Szánthó E, Nagy AC, Müller J, Simon R, Vojczek Á, Szegedi I, Tiszlavicz LG, Kowalczyk JR, et al. Expression Patterns of Coagulation Factor XIII Subunit A on Leukemic Lymphoblasts Correlate with Clinical Outcome and Genetic Subtypes in Childhood B-cell Progenitor Acute Lymphoblastic Leukemia. Cancers. 12. PMID 32823516 DOI: 10.3390/Cancers12082264  0.322
2020 Zsigrai S, Kalmár A, Nagy ZB, Barták BK, Valcz G, Szigeti KA, Galamb O, Dankó T, Sebestyén A, Barna G, Szabó V, Pipek O, Medgyes-Horváth A, Csabai I, Tulassay Z, et al. S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression. Cells. 9. PMID 32784836 DOI: 10.3390/Cells9081864  0.334
2020 Galamb O, Kalmár A, Sebestyén A, Dankó T, Kriston C, Fűri I, Hollósi P, Csabai I, Wichmann B, Krenács T, Barták BK, Nagy ZB, Zsigrai S, Barna G, Tulassay Z, et al. Promoter Hypomethylation and Increased Expression of the Long Non-coding RNA LINC00152 Support Colorectal Carcinogenesis. Pathology Oncology Research : Por. PMID 32307642 DOI: 10.1007/S12253-020-00800-8  0.375
2020 Sarkadi B, Meszaros K, Krencz I, Canu L, Krokker L, Zakarias S, Barna G, Sebestyen A, Papay J, Hujber Z, Butz H, Darvasi O, Igaz P, Doczi J, Luconi M, et al. Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas. Cancers. 12. PMID 32150977 DOI: 10.3390/Cancers12030599  0.46
2019 Gyurina K, Kárai B, Ujfalusi A, Hevessy Z, Barna G, Jáksó P, Pálfi-Mészáros G, Póliska S, Scholtz B, Kappelmayer J, Zahuczky G, Kiss C. Coagulation FXIII-A Protein Expression Defines Three Novel Sub-populations in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia Characterized by Distinct Gene Expression Signatures. Frontiers in Oncology. 9: 1063. PMID 31709175 DOI: 10.1182/Blood-2019-124333  0.333
2019 Szentkereszty M, Komlósi ZI, Szűcs G, Barna G, Tamási L, Losonczy G, Gálffy G. Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer. Pathology Oncology Research : Por. PMID 31090020 DOI: 10.1007/S12253-019-00661-W  0.334
2019 Kiszner G, Balla P, Wichmann B, Barna G, Baghy K, Nemeth IB, Varga E, Furi I, Toth B, Krenacs T. Exploring Differential Connexin Expression across Melanocytic Tumor Progression Involving the Tumor Microenvironment. Cancers. 11. PMID 30717194 DOI: 10.3390/Cancers11020165  0.34
2018 Takács F, Tolnai-Kriston C, Hernádfői M, Szabó O, Szalóki G, Szepesi Á, Czeti Á, Matolcsy A, Barna G. The Effect of CD86 Expression on the Proliferation and the Survival of CLL Cells. Pathology Oncology Research : Por. PMID 30406401 DOI: 10.1007/S12253-018-0512-7  0.336
2018 Németh K, Szücs N, Czirják S, Reiniger L, Szabó B, Barna G, Karászi K, Igaz P, Zivkovic V, Korbonits M, Patócs A, Butz H. Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas. Oncotarget. 9: 29180-29192. PMID 30018744 DOI: 10.18632/Oncotarget.25650  0.5
2018 Kriston C, Plander M, Márk Á, Sebestyén A, Bugyik E, Matolcsy A, Barna G. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment. Annals of Hematology. PMID 29955944 DOI: 10.1007/S00277-018-3410-X  0.519
2017 Barna G, Tolnai-Kriston C, Hernádfői M, Plander M, Takács F, Matolcsy A. THE EFFECT OF AN IMMUNOMODULATORY DRUG ON THE VIABILITY AND SURFACE MOLECULE EXPRESSION OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS Hematological Oncology. 35: 403-403. DOI: 10.1002/Hon.2439_178  0.336
2016 Márk Á, Varga G, Timár B, Kriston C, Szabó O, Deák L, Matolcsy A, Barna G. The effect of microenvironmental factors on the development of myeloma cells. Hematological Oncology. PMID 27766647 DOI: 10.1002/Hon.2354  0.398
2016 Grolmusz VK, Karászi K, Micsik T, Tóth EA, Mészáros K, Karvaly G, Barna G, Szabó PM, Baghy K, Matkó J, Kovalszky I, Tóth M, Rácz K, Igaz P, Patócs A. Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer. American Journal of Cancer Research. 6: 2041-2053. PMID 27725909  0.345
2015 Kriston C, Bödör C, Szenthe K, Bánáti F, Bánkuti B, Csernus B, Reiniger L, Csomor J, Matolcsy A, Barna G. Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL. Hematological Oncology. PMID 26119874 DOI: 10.1002/Hon.2244  0.301
2015 Balla P, Maros ME, Barna G, Antal I, Papp G, Sapi Z, Athanasou NA, Benassi MS, Picci P, Krenacs T. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone. Plos One. 10: e0125316. PMID 25933380 DOI: 10.1371/Journal.Pone.0125316  0.401
2015 Sebestyén A, Márk Á, Hajdu M, Nagy N, Molnár A, Végs? G, Barna G, Kopper L. Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas. Cytokine. 73: 219-24. PMID 25794661 DOI: 10.1016/J.Cyto.2015.02.024  0.634
2015 Zóka A, Barna G, Somogyi A, Műzes G, Oláh Á, Al-Aissa Z, Hadarits O, Kiss K, Firneisz G. Extension of the CD4⁺Foxp3⁺CD25(-/low) regulatory T-cell subpopulation in type 1 diabetes mellitus. Autoimmunity. 48: 289-97. PMID 25523632 DOI: 10.3109/08916934.2014.992518  0.328
2014 Sári E, Nagy ZG, Baghy K, Rajnai H, Bödör C, Csomor J, Barna G, Rudas G, Kovalszky I, Demeter J. Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt. Pathology Oncology Research : Por. 20: 973-80. PMID 24789721 DOI: 10.1007/S12253-014-9783-9  0.374
2013 Nemes K, Sebestyén A, Márk A, Hajdu M, Kenessey I, Sticz T, Nagy E, Barna G, Váradi Z, Kovács G, Kopper L, Csóka M. Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL). Plos One. 8: e59335. PMID 23573198 DOI: 10.1371/Journal.Pone.0059335  0.602
2012 Barna G, Sebestyén A, Dunai ZA, Csernus B, Mihalik R. Heparin can liberate high molecular weight DNA from secondary necrotic cells. Cell Biology International. 36: 1281-6. PMID 22953972 DOI: 10.1042/Cbi20120189  0.476
2012 Dunai ZA, Imre G, Barna G, Korcsmaros T, Petak I, Bauer PI, Mihalik R. Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. Plos One. 7: e41945. PMID 22860037 DOI: 10.1371/Journal.Pone.0041945  0.446
2012 Jókai H, Marschalkó M, Csomor J, Szakonyi J, Kontár O, Barna G, Kárpáti S, Holló P. Tissue-specific homing of immune cells in malignant skin tumors. Pathology Oncology Research : Por. 18: 749-59. PMID 22528565 DOI: 10.1007/S12253-012-9529-5  0.325
2011 Varga T, Somogyi A, Barna G, Wichmann B, Nagy G, Rácz K, Selmeci L, Firneisz G. Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes. Pathology Oncology Research : Por. 17: 925-30. PMID 21785903 DOI: 10.1007/S12253-011-9404-9  0.3
2011 Egervári G, Márk A, Hajdu M, Barna G, Sápi Z, Krenács T, Kopper L, Sebestyén A. Mitotic lymphoma cells are characterized by high expression of phosphorylated ribosomal S6 protein. Histochemistry and Cell Biology. 135: 409-17. PMID 21424608 DOI: 10.1007/S00418-011-0803-5  0.65
2011 Barna G, Mihalik R, Timár B, Tömböl J, Csende Z, Sebestyén A, Bödör C, Csernus B, Reiniger L, Peták I, Matolcsy A. ROR1 expression is not a unique marker of CLL. Hematological Oncology. 29: 17-21. PMID 20597086 DOI: 10.1002/Hon.948  0.423
2010 Kenessey I, Keszthelyi M, Krámer Z, Berta J, Adám A, Dobos J, Mildner M, Flachner B, Cseh S, Barna G, Szokol B, Orfi L, Kéri G, Döme B, Klepetko W, et al. Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma. Current Cancer Drug Targets. 10: 332-42. PMID 20370683 DOI: 10.2174/156800910791190184  0.41
2009 Hauser P, Hanzély Z, Máthé D, Szabó E, Barna G, Sebestyén A, Jeney A, Schuler D, Fekete G, Garami M. Effect of somatostatin analogue octreotide in medulloblastoma in xenograft and cell culture study. Pediatric Hematology and Oncology. 26: 363-74. PMID 19579083 DOI: 10.1080/08880010902973293  0.318
2009 Réti A, Barna G, Pap E, Adleff V, L Komlósi V, Jeney A, Kralovánszky J, Budai B. Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells. Pathology Oncology Research : Por. 15: 335-44. PMID 19048402 DOI: 10.1007/S12253-008-9126-9  0.436
2008 Barna G, Reiniger L, Tátrai P, Kopper L, Matolcsy A. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL. Hematological Oncology. 26: 167-70. PMID 18381689 DOI: 10.1002/Hon.855  0.545
2007 Sebestyén A, Hajdu M, Kis L, Barna G, Kopper L. Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells. Experimental Cell Research. 313: 3167-74. PMID 17643425 DOI: 10.1016/J.Yexcr.2007.05.028  0.708
2007 Végso G, Sebestyén A, Paku S, Barna G, Hajdu M, Tóth M, Járay J, Kopper L. Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas. Leukemia Research. 31: 1003-8. PMID 17320952 DOI: 10.1016/J.Leukres.2006.12.019  0.663
2007 Hajdu M, Sebestyén A, Barna G, Reiniger L, Jánosi J, Sréter L, Várkonyi J, Demeter J, Kopper L. Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells. Scandinavian Journal of Immunology. 65: 271-5. PMID 17309782 DOI: 10.1111/J.1365-3083.2006.01897.X  0.584
2007 Sebestyén A, Hajdu M, Barna G, Kopper L. 381 POSTER Rapamycin potentiates the apoptotic effect of TGFb in lymphoma cells European Journal of Cancer Supplements. 5: 79. DOI: 10.1016/S1359-6349(07)70399-3  0.639
2006 Ihrlund LS, Hernlund E, Viktorsson K, Panaretakis T, Barna G, Sabapathy K, Linder S, Shoshan MC. Two distinct steps of Bak regulation during apoptotic stress signaling: different roles of MEKK1 and JNK1. Experimental Cell Research. 312: 1581-9. PMID 16529740 DOI: 10.1016/j.yexcr.2006.01.023  0.337
2005 Barna G, Sebestyén A, Weischede S, Peták I, Mihalik R, Formelli F, Kopper L. Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cells. Anticancer Research. 25: 4179-85. PMID 16309214  0.661
2005 Nagy K, Petak I, Imre G, Barna G, Gezane-Csorba M, Sebestyen A, Houghton JA, Mihalik R, Kopper L. Proteasome inhibitors abolish cell death downstream of caspase activation during anti-microtubule drug-induced apoptosis in leukemia cells. Anticancer Research. 25: 3321-6. PMID 16101145  0.693
2005 Sebestyén A, Barna G, Nagy K, Jánosi J, Paku S, Kohut E, Berczi L, Mihalik R, Kopper L. Smad signal and TGFbeta induced apoptosis in human lymphoma cells. Cytokine. 30: 228-35. PMID 15927846 DOI: 10.1016/J.Cyto.2005.01.013  0.728
2004 Jánosi J, Sebestyén A, Bocsi J, Barna G, Nagy K, Vályi-Nagy I, Kopper L. [Mevastatin induced apoptosis in U266 human myeloma cell line]. Magyar Onkologia. 48: 333-7. PMID 15655579  0.731
2004 Dobos J, Tímár J, Bocsi J, Burián Z, Nagy K, Barna G, Peták I, Ladányi A. In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. International Journal of Cancer. 112: 771-6. PMID 15386380 DOI: 10.1002/Ijc.20473  0.665
2004 Jánosi J, Sebestyén A, Bocsi J, Barna G, Nagy K, Vályi-Nagy I, Kopper L. Mevastatin-induced apoptosis and growth suppression in U266 myeloma cells. Anticancer Research. 24: 1817-22. PMID 15274361  0.729
2002 Barna G, Sebestyén A, Chinopoulos CC, Nagy K, Mihalik R, Paku S, Kopper L. TGF beta 1 kills lymphoma cells using mitochondrial apoptotic pathway with the help of caspase-8. Anticancer Research. 22: 3867-72. PMID 12553006  0.724
2001 Tótth A, Sebestyén A, Barna G, Nagy K, Göndör A, Bocsi J, Mihalik R, Peták I, Houghton J, Kopper L. TGF beta 1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells. Anticancer Research. 21: 1207-12. PMID 11396165  0.73
2001 Sebestyen A, Barna G, Gondor A, Nagy K, Weishede S, Bauer P, Kopper L. The apoptotic effect of TGF-beta in human lymphoma cells European Journal of Cancer. 37: S123. DOI: 10.1016/S0959-8049(01)80941-2  0.607
1999 Mihalik R, Sebestyén A, Barna G, Bauer P, Kopper L. Death receptors in etoposide treated lymphoma cells European Journal of Cancer. 35: S104. DOI: 10.1016/S0959-8049(99)80798-9  0.598
Show low-probability matches.